Mirum (MIRM) CFO Eric Bjerkholt Sells 6,001 Shares

What Happened Eric Bjerkholt, Chief Financial Officer of Mirum Pharmaceuticals (MIRM), sold 6,001 shares of Mirum common stock in an open‑market transaction on August 11, 2026. The shares were disposed at an aggregate value of approximately $599,510 (weighted average sale price $99.901633).

Key Details

• Transaction date: 2026-08-11 (reported on Form 4 filed 2026-08-12). The filing appears timely.
• Sale type: Open-market sale (Code S).
• Shares sold: 6,001 at a weighted average price of $99.901633; reported price range $99.90–$99.93. The issuer can provide the number of shares sold at each specific price on request.
• Total proceeds: ~$599,510.
• Footnotes: Transaction executed pursuant to a Rule 10b5‑1 plan adopted March 9, 2026 (F1). Footnote also notes 175 shares were acquired by the reporting person on May 10, 2026 under the company ESPP (F3).
• Shares owned after transaction: Not specified in the provided filing details.

Context This was a sale under a prearranged 10b5‑1 trading plan, which is commonly used to schedule insider trades in advance and reduce questions about timing. Sales do not necessarily indicate negative company outlook; purchases generally carry more informational weight for retail investors.